ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,908Medicare Part D Prescriptions Filled, Including Refills

Rank: 340 out of 3647

$1.02M Total Retail Price of All Prescriptions

Rank: 217 out of 3647

547 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 547 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

2% of this provider’s 547 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 15,720 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
METOPROLOL TARTRATE 595 551 1 7
SIMVASTATIN 566 556 2 1
LEVOTHYROXINE SODIUM 532 512 3 5
ALBUTEROL SULFATE 416 396 4 157
AMLODIPINE BESYLATE 410 391 5 2
LISINOPRIL 391 388 6 4
FUROSEMIDE 336 308 7 8
CITALOPRAM HBR 309 297 8 25
OMEPRAZOLE 286 277 9 3
DONEPEZIL HCL 280 280 10 30
NAMENDA 258 258 11 49
CARVEDILOL 248 246 12 20
CRESTOR 242 218 13 19
IPRATROPIUM BROMIDE 235 225 14 210
LANTUS 234 204 15 59
RISPERIDONE 230 205 16 83
CLOPIDOGREL 226 212 17 26
GABAPENTIN 225 218 18 17
QUETIAPINE FUMARATE 207 172 19 89
FAMOTIDINE 196 169 20 61
WARFARIN SODIUM 174 174 21 15
METFORMIN HCL 170 145 22 6
GLIPIZIDE 159 140 23 41
ESCITALOPRAM OXALATE 157 146 24 65
DIGOXIN 154 150 25 51
PLAVIX 150 144 26 39
EXELON 149 149 27 129
NOVOLIN R 148 133 28 139
TRAMADOL HCL 146 138 29 22
HUMULIN R 146 137 29 370
NEXIUM 137 127 31 44
LEVOFLOXACIN 135 124 32 87
LOSARTAN POTASSIUM 134 133 33 11
MIRTAZAPINE 132 132 34 63
SANTYL 130 122 35 233
NOVOLOG 130 123 35 123
ADVAIR DISKUS 126 118 37 52
TAMSULOSIN HCL 121 107 38 28
CLONIDINE HCL 120 111 39 46
LEVETIRACETAM 118 87 40 122
RANITIDINE HCL 118 112 40 29
SERTRALINE HCL 115 115 42 27
BACLOFEN 109 91 43 97
METOPROLOL SUCCINATE 109 106 43 18
DIOVAN 108 108 45 40
MEGESTROL ACETATE 108 107 R 45 138
MUPIROCIN 105 95 47 137
ISOSORBIDE MONONITRATE ER 104 104 48 56
LACTULOSE 102 86 49 128
TRIAMTERENE-HCTZ 99 98 50 58
SILVER SULFADIAZINE 99 78 50 243
POTASSIUM CHLORIDE 98 98 52 24
ENALAPRIL MALEATE 96 85 53 35
SEROQUEL 90 79 54 185
CARBIDOPA-LEVODOPA 87 87 55 127
ATENOLOL 85 83 56 10
ZOLPIDEM TARTRATE 82 75 57 14
VALPROIC ACID 81 59 58 331
OLANZAPINE 79 79 59 240
LIDODERM 79 79 59 108
LATANOPROST 75 75 61 218
SINGULAIR 75 75 61 90
KETOCONAZOLE 74 72 63 132
IPRATROPIUM-ALBUTEROL 74 70 63 150
HYDROCHLOROTHIAZIDE 73 73 65 9
IBUPROFEN 71 68 66 55
ATORVASTATIN CALCIUM 71 64 66 13
PRAVASTATIN SODIUM 71 56 66 16
ALLOPURINOL 70 70 69 37
TRAZODONE HCL 67 54 70 64
MELOXICAM 63 63 71 33
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 56 71 110
METOCLOPRAMIDE HCL 62 58 73 135
DILTIAZEM 24HR CD 61 61 74 155
RAMIPRIL 59 57 75 101
AZITHROMYCIN 59 50 75 34
ISOSORBIDE DINITRATE 57 57 77 363
MECLIZINE HCL 56 54 78 85
LEXAPRO 56 50 78 177
SPIRONOLACTONE 53 50 80 77
GENERLAC 52 51 81 278
ENOXAPARIN SODIUM 50 50 82 275
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.